Listing products for immune system boosting & stimulation to help fight disease and infection HOME Immune Report Search this Site

MORE INFORMATION ON: RELENZA

NOTICE:  For your convenience we copied key information from each product's site and have provided it here, with some content edited to make it more readable.

FDA has approved Relenza (zanamivir), an anti-viral drug, for persons aged 7 years and older for the treatment of uncomplicated influenza virus. This product is approved to treat type A and B influenza, the two types most responsible for flu epidemics. Clinical studies showed that for the drug to be effective, patients needed to start treatment within two days of the onset of symptoms. The drug seemed to be less effective in patients whose symptoms weren't severe or didn't include a fever.

Relenza is a powder that is inhaled twice a day for five days from a breath-activated plastic device called a Diskhaler. Patients should get instruction from a health-care practitioner in the proper use of the Diskhaler, including a demonstration when possible. Relenza has not been shown to be effective, and may carry risk, in patients with severe asthma or a lung condition called chronic obstructive pulmonary disease. Some patients with mild or moderate asthma experienced bronchospasm (marked by shortness of breath) after using Relenza.

Some patients have had bronchospasm (wheezing) or serious breathing problems when they used Relenza. Many but not all of these patients had previous asthma or chronic obstructive pulmonary disease. Relenza has not been shown to shorten the duration of influenza in people with these diseases. Because of the risk of side effects and because it has not been shown to help them, Relenza is not generally recommended for people with chronic respiratory disease. Anyone who develops bronchospasm worsening respiratory symptoms such as wheezing and shortness of breath should stop taking the drug and call their health-care provider. Patients with underlying respiratory disease should have a fast-acting inhaled bronchodilator available when taking Relenza.

Relenza is not approved for use in prevention of influenza (prophylaxis) and is not a substitute for influenza vaccine.

1 Based on information obtained from manufacturer's/retailer's website.
2 Reflects approximately average retail price as provided by popular online drugstores and other supplement outlets.
3 Reflects approximately average shipping costs as provided by popular online drugstores and other supplement outlets.
4 Our opinion only, not based on statistical analysis of study results supplied by manufacturer or other source.
5 Based on our opinion only, calculated by considering its price, shipping costs, efficacy, ingredients/content, value or any combination of the categories.